Valeant completes purchase of Bausch & Lomb Valeant Pharmaceuticals (VRX) completes the $8.7B acquisition of Bausch & Lomb. Valeant expects savings of over $800M from the deal, including more than $500M this year. http://seekingalpha.com/news-article/7258532-valeant-pharmaceuticals-international-inc-completes-acquisition-of-bausch-lomb